Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children.

Mehdi Oualha 1, 2, * Saïk Urien 2 Odile Spreux-Varoquaux 3 Alice Bordessoule 4 Irène D'Agostino 4 Philippe Pouard 4 Jean-Marc Tréluyer 2
* Auteur correspondant
1 Réanimation Pédiatrique
2 Infections à Vih, Réservoirs, Pharmacologie des Antirétroviraux et Prévention de la Transmission Mère Enfant
3 Unité de Pharmacologie - Toxicologie
4 Réanimation Chirurgicale Cardiaque Pédiatrique
Abstract : INTRODUCTION: The response to exogenous epinephrine (Ep) is difficult to predict given the multitude of factors involved such as broad pharmacokinetic and pharmacodynamic between-subject variabilities, which may be more pronounced in children. We investigated the pharmacokinetics and pharmacodynamics of Ep, co-administered with milrinone, in children who underwent open heart surgical repair for congenital defects following cardiopulmonary bypass, including associated variability factors. METHODS: Thirty-nine children with a high risk of low cardiac output syndrome were prospectively enrolled. Ep pharmacokinetics, hemodynamic and metabolic effects were analyzed using the non-linear mixed effects modeling software MONOLIX. According to the final model, an Ep dosing simulation was suggested. RESULTS: Ep dosing infusions ranged from 0.01 to 0.23 mug.kg-1.min-1 in children whose weight ranged from 2.5 to 58 kg. A one-compartment open model with linear elimination adequately described the Ep concentration-time courses. Bodyweight (BW) was the main covariate influencing clearance (CL) and endogenous Ep production rate (q0) via an allometric relationship: CL(BWi) = thetaCL x (BWi)3/4 and q0(BWi) = thetaq0 x (BWi )3/4. The increase in heart rate (HR) and mean arterial pressure (MAP) as a function of Ep concentration were well described using an Emax model. The effect of age was significant on HR and MAP basal level parameters. Assuming that Ep stimulated the production rate of plasma glucose, the increases in plasma glucose and lactate levels were well described by turnover models without any significant effect of age, BW or exogenous glucose supply. CONCLUSIONS: According to this population analysis, the developmental effects of BW and age explained a part of the pharmacokinetic and pharmacodynamics between-subject variabilities of Ep administration in critically ill children. This approach ultimately leads to a valuable Ep dosing simulation which should help clinicians to determine an appropriate a priori dosing regimen.
Type de document :
Article dans une revue
Critical Care, BioMed Central, 2014, 18 (1), pp.R23. 〈10.1186/cc13707〉
Liste complète des métadonnées

Littérature citée [34 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00945727
Contributeur : Ed. Bmc <>
Soumis le : mercredi 12 février 2014 - 17:34:21
Dernière modification le : mardi 5 décembre 2017 - 16:50:03

Fichiers

cc13707.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UNIV-PARIS5 | UVSQ | USPC

Citation

Mehdi Oualha, Saïk Urien, Odile Spreux-Varoquaux, Alice Bordessoule, Irène D'Agostino, et al.. Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children.. Critical Care, BioMed Central, 2014, 18 (1), pp.R23. 〈10.1186/cc13707〉. 〈inserm-00945727〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

758

Téléchargements de fichiers

1037

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD